• Users Online: 186
  • Home
  • Print this page
  • Email this page

  Disclaimer and Copyrights

The entire contents of the Carcinomics and Clinical Communications are protected under international copyrights. The Journal, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also grants the right to make small numbers of printed copies for their personal non-commercial use. LOCKSS system has permission to collect, preserve, and serve this open access Archival Unit.
Important notice on reuse, reproduction or commercial use:
  1. Contents of this site, partial or as a whole, should not be included in a framed web page.
  2. Contents of this site, partial or as a whole, should not be included in a password protected site or a site which requires registration, even if free.
  3. Contents of this site, partial or as a whole, should not be included in a site which charges for other contents but provides the content from this site for free.
  4. For purchase of reprints, printable PDF or commercial reuse please contact Medknow Publications (publishing @ medknow.com) or the executive editor of the Carcinomics and Clinical Communications.

Neither the Carcinomics and Clinical Communications nor its publishers nor anyone else involved in creating, producing or delivering the Carcinomics and Clinical Communications (in printed, web or CD format) or the materials contained therein, assumes any liability or responsibility for the accuracy, completeness, or usefulness of any information provided in the Carcinomics and Clinical Communications (in printed, web or CD format), nor shall they be liable for any direct, indirect, incidental, special, consequential or punitive damages arising out of the use of the Carcinomics and Clinical Communications.

All material published in the Carcinomics and Clinical Communications undergoes peer review to ensure fair balance, objectivity, independence, and relevance to educational need. Neither the editors of the Carcinomics and Clinical Communications, nor its publishers, nor any other party involved in the preparation of material contained in the Carcinomics and Clinical Communications represent or warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such material. Patients and consumers reading articles posted on the website of the Carcinomics and Clinical Communications should review the information carefully with their professional healthcare provider. The information is not intended to replace medical advice offered by the physicians. The Carcinomics and Clinical Communications and its publishers make no representations or warranties with respect to any treatment, action, or application of medication or preparation by any person following the information offered or provided within or through the Carcinomics and Clinical Communications. The Carcinomics and Clinical Communications, and its publishers will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising therefrom.

The advertisers who purchase Banners on the Carcinomics and Clinical Communications have no influence on editorial content or presentation. The posting of particular Banners does not imply endorsement of the product (so) or the company selling them by the Carcinomics and Clinical Communications or its Editors.

Carcinomics and Clinical Communications may contain links to web sites operated by other parties. These links are provided purely for educational purpose. Such links do not imply Carcinomics and Clinical Communications's endorsement of material on any other site and Carcinomics and Clinical Communications disclaims all liability with regard to your access of such linked web sites.

What's new
Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal